BES
2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID
Find entries where: BES
is present as a standalone ligand in 30 entries
Chemical Component Summary | |
---|---|
Name | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID |
Synonyms | BESTATIN |
Identifiers | (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid |
Formula | C16 H24 N2 O4 |
Molecular Weight | 308.373 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](Cc1ccccc1)N)O |
InChI | InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1 |
InChIKey | VGGGPCQERPFHOB-RDBSUJKOSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 46 |
Chiral Atom Count | 3 |
Bond Count | 46 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB03424? |
---|---|
Name | Ubenimex |
Groups | investigational |
Description | Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. |
Synonyms |
|
Indication | An adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia. |
Categories |
|
CAS number | 58970-76-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Bacterial leucyl aminopeptidase | MKYTKTLLAMVLSATFCQAYAEDKVWISIGADANQTVMKSGAESILPNSV... | unknown | |
Leukotriene A-4 hydrolase | MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNL... | unknown | |
Dipeptidase 1 | MWSGWWLWPLVAVCTADFFRDEAERIMRDSPVIDGHNDLPWQLLDMFNNR... | unknown | inhibitor |
Solute carrier family 15 member 1 | MGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDN... | unknown | inhibitor |
Solute carrier family 15 member 2 | MNPFQKNESKETLFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIV... | unknown | substrate,inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL29292 |
PubChem | 6992132, 72172 |
ChEMBL | CHEMBL29292 |